Transcription of the caspase-14 gene in human epidermal keratinocytes requires AP-1 and NFκB

https://doi.org/10.1016/j.bbrc.2008.04.050Get rights and content

Abstract

Caspase-14, a protease involved in skin barrier formation, is specifically expressed in epidermal keratinocytes (KCs). Here, we mapped three start sites of transcription of the human caspase-14 gene and analyzed the upstream chromosomal region for promoter activity. Reporter gene assays identified a core promoter region proximal to the first exon and a distal regulatory region which differentially suppressed promoter activity in KC and other cells. Sequence elements in the proximal promoter were bound by the transcription factors AP-1 (JunB, c-Jun, JunD, Fra-1 and Fra-2) and NFκB (p50 and RelB). Our data reveal the basic organization of the human caspase-14 promoter and suggest an important role of AP-1 and NFκB in the transcriptional control of caspase-14.

Section snippets

Materials and methods

In silicopromoter analysis. Nucleotide sequences were obtained from the GenBank (human chromosome 19, build 36 version 2 of the NCBI’s genome annotation). The caspase-14 promoter region was investigated using the algorithms TFSEARCH (Parallel Application TRC Laboratory, RWCP, Japan) and IFTI-MIRAGE Tfsitescan.

Cell culture and in vitro organotypic skin cultures. KCs derived from neonatal foreskin of single donors were purchased from Lonza (Basel, Switzerland). The secondary human lung fibroblast

Cloning and promoter analysis of the 5′-end of the human caspase-14 gene

In a previous report, we have shown that the open reading frame of human caspase-14 is localized on six exons which are preceded on the 5′-side by an additional exon that lacks coding sequence [6]. Here, we have extended these studies by performing primer extension assays and RLM-RACE PCR on RNA from differentiated human primary KCs to map the start site(s) of transcription. Both methods yielded the same results and only RACE data are presented here. Transcription of caspase-14 was initiated at

Discussion

Our study defines the proximal promoter of human caspase-14 and implicates the two transcription factors AP-1 and NFκB in the basal transcriptional regulation of caspase-14.

AP-1 is a dimeric protein complex comprising members of the Jun and Fos proto-oncogene subfamilies in various combinations [23]. JunB, c-jun and, to a lower extent, JunD as well as fra-1 and fra-2 bound to the caspase-14 AP-1 site. The efficient suppression of caspase-14 expression by specific silencing of JunB indicated

Acknowledgments

We thank Wim Declercq (Ghent University, Belgium) for helpful discussions and Heidemarie Rossiter for critical reading of the manuscript.

References (28)

Cited by (13)

  • Biophysical insights into OR2T7: Investigation of a potential prognostic marker for glioblastoma

    2022, Biophysical Journal
    Citation Excerpt :

    In addition, the expressions of c-Fos, c-Jun, and JunB have been extensively implicated in the progression of gliomas (60–64). p38 MAPK also targets Casp14 and RhoB transcription factors, which include c-Jun and JunB, to their promoter sites (65–69). Casp14 and RhoB have also been shown to suppress tumor growth (67,69–76), although in some cases they have been associated with promoting tumor growth (77–79).

  • An updated view on the functions of caspases in inflammation and immunity

    2018, Seminars in Cell and Developmental Biology
    Citation Excerpt :

    Last, caspase-14 is restricted to the skin, both in humans and mice, where it functions in keratinocyte differentiation [217,218]. Whether it exerts roles in inflammation is not clear but its expression is induced in human psoriasis patients lesions [219] and is regulated by NF-κB and AP-1 [220]. Furthermore, Casp14−/− mice has a mild skin microbiota dysbiosis [221], which could stem from direct or indirect regulatory function of caspase-14 in mucosal immunity.

  • Caspases Connect Cell-Death Signaling to Organismal Homeostasis

    2016, Immunity
    Citation Excerpt :

    Fragmentary evidence suggests that CASP14 may also participate in the regulation of inflammatory responses in the skin. Indeed, CASP14 is under the control of several transcription factors with pro- and anti-inflammatory functions; such transcription factors include NF-κB (which controls CASP14 expression in human epidermal keratinocytes) (Ballaun et al., 2008) and nuclear receptor subfamily 3, group C, member 1 (NR3C1, best known as glucocorticoid receptor, which influences Casp14 activation in the epidermis of late mouse embryos) (Bayo et al., 2008). Moreover, psoriasis (a skin disorder with a prominent inflammatory component) has been associated with altered expression of CASP14 in patient biopsies (Walsh et al., 2005), and the skin of Casp14−/− mice exhibits a mild form of dysbiosis as compared to that of wild-type mice (Kubica et al., 2014), possibly indicating an alteration in the immunological control of symbiotic bacteria.

  • A guide for building biological pathways along with two case studies: Hair and breast development

    2015, Methods
    Citation Excerpt :

    Casp14 is known to play a role in apoptosis, and in addition, it is directly associated with epidermal cell differentiation [76,77]. Casp14 is also upregulated by NF-kappaB and FOS, although downregulated by JUN [78]. However, both upregulators are suppressed by GPRC5D and NR3C1, respectively [79,80].

  • ROS and NF-κB are involved in upregulation of IL-8 in A549 cells exposed to multi-walled carbon nanotubes

    2009, Biochemical and Biophysical Research Communications
    Citation Excerpt :

    Western blotting and electrophoretic mobility shift assay (EMSA). Preparation of cell lysates and Western blotting were performed as described previously [19]. Nuclear extracts from A549 cells incubated with MWCNTs were prepared as described previously [20].

  • Pyroptosis: Role and Mechanisms in Cardiovascular Disease

    2022, Frontiers in Cardiovascular Medicine
View all citing articles on Scopus
1

Present address: Immunology Program, The Wistar Institute, Philadelphia, PA 19104, USA.

2

Present address: Children’s Cancer Research Institute, A-1090 Vienna, Austria.

View full text